Drug recall D-1876-2019
Product
Nucala (mepolizumab) Injection, 100 mg/mL Prefilled Syringe, Single-Dose, For subcutaneous use only, Rx Only, Manufactured by GlaxoSmithKline LLC, Philadelphia, PA 19112, Distributed by GlaxoSmithKline, Research Triangle Park, NC 27709, NDC 0173-0892-42.
Reason for recall
Temperature Abuse; Product stored and shipped outside of labeled storage requirements.
Lots and codes
Lot #: S25X, Exp. 03/31/21
Recall details
- Recalling firm
- Cardinal Health dba Specialty Pharmaceutical Services, La Vergne, TN
- Quantity
- 38 syringes
- Distribution
- Nationwide in the U.S.
- Type
- Voluntary: Firm initiated
- Recall initiated
- September 6, 2019
- Terminated
- October 8, 2020
Related products
- Nucala – drug information
- NDC 0173-0904 Nucala · Mepolizumab 40 mg/.4mL · GlaxoSmithKline LLC
- NDC 0173-0892 Nucala · Mepolizumab 100 mg/mL · GlaxoSmithKline LLC
- NDC 0173-0881 Nucala · Mepolizumab 100 mg/mL · GlaxoSmithKline LLC